Black Diamond Therapeutics GAAP EPS of -$0.15 beats by $0.08
Source: SeekingAlpha
2025-11-06 07:46:37 ET
More on Black Diamond Therapeutics
- Black Diamond Therapeutics: A Potential First-Line In NSCLC Trading At Cash
- Seeking Alpha’s Quant Rating on Black Diamond Therapeutics
- Historical earnings data for Black Diamond Therapeutics
- Financial information for Black Diamond Therapeutics
Read the full article on Seeking Alpha
For further details see:
Black Diamond Therapeutics GAAP EPS of -$0.15 beats by $0.08
Black Diamond Therapeutics Inc.
NASDAQ: BDTX
BDTX Trading
2.54% G/L:
$2.22 Last:
228,763 Volume:
$2.19 Open:
BDTX Latest News
BDTX Stock Data
$131,327,174
47,334,758
0.19%
22
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
